about
Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled studyTraditional Chinese medicinal herbs for the treatment of idiopathic chronic fatigue and chronic fatigue syndromeCognitive behaviour therapy for chronic fatigue syndrome in adultsContrasting case definitions for chronic fatigue syndrome, Myalgic Encephalomyelitis/chronic fatigue syndrome and myalgic encephalomyelitisUnderstanding Muscle Dysfunction in Chronic Fatigue SyndromeXenotropic murine leukemia virus-related virus (XMRV) and blood transfusion: report of the AABB interorganizational XMRV task forceTracking post-infectious fatigue in clinic using routine Lab testsMetabolic features of chronic fatigue syndromeFrom good health to illness with post-infectious fatigue syndrome: a qualitative study of adults' experiences of the illness trajectory.Fatigue Intervention by Nurses Evaluation--the FINE Trial. A randomised controlled trial of nurse led self-help treatment for patients in primary care with chronic fatigue syndrome: study protocol. [ISRCTN74156610].Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndromeHealth care resource use by patients before and after a diagnosis of chronic fatigue syndrome (CFS/ME): a clinical practice research datalink study.Whole blood gene expression in adolescent chronic fatigue syndrome: an exploratory cross-sectional study suggesting altered B cell differentiation and survival.XMRV and Public Health: The Retroviral Genome Is Not a Suitable Template for Diagnostic PCR, and Its Association with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Appears Unreliable.Daily physical activity of patients with the chronic fatigue syndrome: a systematic review.Housebound versus nonhousebound patients with myalgic encephalomyelitis and chronic fatigue syndrome.Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer.Prevalence of and risk factors for severe cognitive and sleep symptoms in ME/CFS and MSThe functional status and well being of people with myalgic encephalomyelitis/chronic fatigue syndrome and their carersData mining: comparing the empiric CFS to the Canadian ME/CFS case definition.Are Myalgic Encephalomyelitis and chronic fatigue syndrome different illnesses? A preliminary analysis.No evidence for XMRV nucleic acids, infectious virus or anti-XMRV antibodies in Canadian patients with chronic fatigue syndromeDefining recovery in chronic fatigue syndrome: a critical review.Antibody to Epstein-Barr virus deoxyuridine triphosphate nucleotidohydrolase and deoxyribonucleotide polymerase in a chronic fatigue syndrome subset.The debate: myalgic encephalomyelitis and chronic fatigue syndrome.Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study.The chronic fatigue syndrome--an update.Treatment and management of chronic fatigue syndrome/myalgic encephalomyelitis: all roads lead to Rome.Rehabilitation of decreased motor performance in patients with chronic fatigue syndrome: should we treat low effort capacity or reduced effort tolerance?Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome.Measuring substantial reductions in activityComplications in operationalizing lifelong fatigue as an exclusionary criterion.Problems in defining post-exertional malaiseChronic fatigue syndrome versus sudden onset myalgic encephalomyelitis.Are stamina and fatigue polar opposites? A case study.Pharmacological treatment of chronic fatigue syndrome: focusing on the role of antidepressants.A brain MRI study of chronic fatigue syndrome: evidence of brainstem dysfunction and altered homeostasis.Gene expression alterations at baseline and following moderate exercise in patients with Chronic Fatigue Syndrome and Fibromyalgia Syndrome.Response to vitamin B12 and folic acid in myalgic encephalomyelitis and fibromyalgia.Submaximal exercise testing with near-infrared spectroscopy in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients compared to healthy controls: a case-control study
P2860
Q21089923-80BB27EF-32A4-49E1-9D0D-EF33868CC8FDQ24240035-7B3AEE7E-5315-46FD-9048-1EC100A005D7Q24242121-C89B3622-45F4-48E8-8B3D-37CA398EBFA9Q24623491-047AF597-D65F-4FAF-8698-28CD533A8585Q26753111-11D18FDC-76F6-434B-ABD9-52185CFB41A7Q28303254-84DB21E7-0A0D-4AA8-AB59-423C45E82E9CQ28393209-ED1FAC1E-2532-441A-8F21-388EAFC3F0DBQ28829926-C5C56E4D-3332-41E5-A1F3-F6FCA8841F12Q30843149-7B01A151-8504-4DA1-94C9-1E96B1A882FBQ33239300-3F7B8CCC-ACF7-45A6-8101-F244FF2BCE69Q33604317-3AAD5DDE-7E94-4179-B6A3-5D2EDC30A5DEQ33644694-8DCCEC3C-D46E-4ECC-B4B3-868B1C6BA612Q33660262-CCD2CC37-45BD-49E9-A19D-6621C8115C84Q33711512-7FAA2ADB-8A63-408C-B111-AD17F318C56EQ33718165-EFB60CFF-B4F8-4027-900C-1DDBB5DECA29Q33778012-A8F00A4E-8CD0-4780-BEF5-55246122FD2EQ33810027-4BADA153-6FD8-4F4C-90AF-06B4A3070FB7Q33816383-C730CB6B-DB37-4B01-80A3-33845DA53339Q33914325-0FBC174B-0BE7-4318-80CD-A46A76501E47Q33984948-117D0721-FCB9-467D-BDBF-7856D2D291FDQ34017326-9247B5A5-48EB-4B82-8D38-4A45F9ED82DDQ34082930-439BF432-1C4D-4836-AA58-D9AF37BD8D18Q34418575-A8027F0E-11BA-473B-9C4E-178366CEC828Q34478959-6FB6757A-3D57-4F15-A120-0A0F71A2F9AEQ34546727-63369DFA-6AEF-447E-AA5B-EE08A8B35CE8Q34553410-F6306080-BBB1-41F2-9F44-07DF9B760186Q34617401-828B54C4-6293-422F-B15C-7F7905D8F360Q34680436-18B54073-E2F0-4BF1-9B5C-0608A636CE8EQ34718741-77682C96-4BE4-4056-B271-39F87A28A472Q34775183-36C203D1-9C0C-4790-A4F0-9C0E1C271089Q34970781-82BB9755-1348-484F-8ABA-D77ADD2C8622Q34970845-98FA5223-817F-485F-AB5B-AA00D14E9DDAQ34970973-08F62E05-D526-4A2D-8502-7FB1B5942DB2Q34971098-712C0DAF-2784-4F2A-AC60-502BCE5A16AEQ34971475-2913689B-A821-45E6-96E8-46FA50937F3DQ34985957-C1BA8204-06DC-48D5-BBEF-5DF49DCDCB85Q35204426-8B463063-74AE-42C2-989E-357F831577A4Q35219064-A1E63507-7365-4EEE-A7FD-30F678BCB68FQ35526128-FEE753B7-9157-4C66-982F-7BFF23FD86A3Q35627076-5BA87DC0-4A99-4AA5-AC23-5E5BF9E22A6B
P2860
description
article
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2003
@uk
ലേഖനം
@ml
name
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
@en
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
@nl
type
label
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
@en
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
@nl
prefLabel
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
@en
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
@nl
P2093
P356
P1476
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
@en
P2093
A. C. Peter Powles
A. Martin Lerner
Anil Kumar Jain
Bruce M. Carruthers
Daniel L. Peterson
Jeffrey A. Sherkey
Kenny L. De Meirleir
Marjorie I. van de Sande
Pierre Flor-Henry
Pradip Joshi
P356
10.1300/J092V11N01_02
P577
2003-01-01T00:00:00Z